MDNYSEServices-HospitalsFiscal year ends December 31
Pediatrix Medical Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$27.30−0.08 (-0.29%)
Close on Oct 19, 2026
- Market cap
- $2.22B
- P/E (TTM)
- 13.1
- Dividend yield
- –
Share price
+$10.85 (+65.96%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Pediatrix Medical Group, Inc. grew revenue 0.5% to $1.95B over the twelve months to Jun 30, 2026. Operating income rose 30.5% to $215.42M, moving the operating margin from 8.5% to 11.0%.
Revenue
$1.95B
+0.5% vs. a year earlier
Operating income
$215.42M
+30.5% vs. a year earlier
EPS, diluted
$2.09
+62.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.22B
- P/E ratio
- 13.1
- Price to sales
- 1.14
- Price to book
- 2.52
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.95B
- Net income
- $174.81M
- EPS, diluted
- $2.09
- Book value per share
- $10.82
- Diluted shares
- 81M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.95B+0.5% YoY
Operating income
$215.42M+30.5% YoY
Net income
$174.81M+59.0% YoY
EPS, diluted
$2.09+62.0% YoY
Reported periodTrailing twelve months